Bethany Sensenig

Insider Reports History

Location
Raleigh, NC
Signature
/s/ Timothy C. Dec, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bethany Sensenig:

Company Role Class Num Shares Value Price $ Report Date Ownership
SUPERNUS PHARMACEUTICALS, INC. Director Restricted Stock Unit 0 $177,658 $39.70 19 Feb 2026 Direct
9 METERS BIOPHARMA, INC. Chief Financial Officer Common stock 41,077 $9,353 $0.2277 21 Apr 2023 Direct
SUPERNUS PHARMACEUTICALS, INC. Director Common Stock 0 $0 $51.27 19 Feb 2026 Direct
SUPERNUS PHARMACEUTICALS, INC. Director Restricted Stock Units 0 $0 $39.70 22 Feb 2025 Direct
KalVista Pharmaceuticals, Inc. Director Stock Option (right to buy) 45,000 01 Oct 2025 Direct
SUPERNUS PHARMACEUTICALS, INC. Director Director Stock Option (Right to Buy) 4,977 18 Feb 2026 Direct

Insider Reports Filed by Bethany Sensenig

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SUPN SUPERNUS PHARMACEUTICALS, INC. 19 Feb 2026 4 -$228,265 4 Director 23 Feb 2026, 16:39
SUPN SUPERNUS PHARMACEUTICALS, INC. 18 Feb 2026 2 $0 4 Director 20 Feb 2026, 16:43
KALV KalVista Pharmaceuticals, Inc. 01 Oct 2025 1 $0 4 Director 02 Oct 2025, 18:28
KALV KalVista Pharmaceuticals, Inc. 01 Oct 2025 0 $0 3 Director 02 Oct 2025, 18:27
SUPN SUPERNUS PHARMACEUTICALS, INC. 14 Aug 2025 1 -$226,840 4 Director 18 Aug 2025, 16:31
SUPN SUPERNUS PHARMACEUTICALS, INC. 22 Feb 2025 2 $0 4 Director 24 Feb 2025, 17:41
SUPN SUPERNUS PHARMACEUTICALS, INC. 19 Feb 2025 2 $0 4 Director 21 Feb 2025, 16:48
SUPN SUPERNUS PHARMACEUTICALS, INC. 22 Feb 2024 2 $0 4 Director 26 Feb 2024, 17:01
SUPN SUPERNUS PHARMACEUTICALS, INC. 17 Aug 2023 1 $0 4 Director 21 Aug 2023, 17:10
SUPN SUPERNUS PHARMACEUTICALS, INC. 17 Aug 2023 0 $0 3 Director 21 Aug 2023, 17:01
/report/000155198623000026-sensenig-bethany-2023-04-21 9 METERS BIOPHARMA, INC. 21 Apr 2023 1 -$11,011 4 Chief Financial Officer 21 Apr 2023, 17:08
/report/000157856323000009-sensenig-bethany-2023-03-27 9 METERS BIOPHARMA, INC. 27 Mar 2023 1 $0 4 Chief Financial Officer 29 Mar 2023, 16:09
/report/000155198622000011-sensenig-bethany-2022-01-18 9 METERS BIOPHARMA, INC. 18 Jan 2022 1 $0 4 Chief Financial Officer 18 Jan 2022, 18:24
/report/000155198622000008-sensenig-bethany-2022-01-17 9 METERS BIOPHARMA, INC. 17 Jan 2022 0 $0 3 Chief Financial Officer 18 Jan 2022, 07:06